1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceutical Analysis & Statistics in Oceania Countries, October 2015 (p6)

Pharmaceutical Analysis & Statistics in Oceania Countries, October 2015 (p6)

151-180 of about 200 reports

Purchase Reports From Reputable Market Research Publishers

Pharmaxis Ltd. (Australia)

  • $ 3500
  • Company report
  • October 2015
  • by Global Industry Analysts

This report presents quick facts about Pharmaxis Ltd., which is principally involved in the Maufacture and Distribution of Pharmaceutical Products. Illustrated with 144 tables, the report showcases the ...

  • Countries : Australia

The Australian Contract Research Organization Market 

  • $ 1500
  • Industry report
  • August 2015
  • by Frost & Sullivan

The Australian Contract Research Organization Market : Early Phase Clinical Trials are Set to Drive the Australian CRO Market This research service presents an overview and analysis of the Australian contract ...

  • Industries : Drug Discovery and Development
  • Countries : Australia

Opioids Overview to 2021 - An Assessment of Pain Management and Dependence

  • $ 2995
  • Industry report
  • August 2015
  • by CBR Pharma Insights

Opioids Overview to 2021 - An Assessment of Pain Management and Dependence Summary GBI Research’s latest report, "Opioids Overview to 2021 - An Assessment of Pain Management and Dependence" discusses ...

  • Industries : Therapy
  • Countries : Europe, Australia, India, Germany, China, United Kingdom, Spain, United States, France, Italy, Japan, Asia

Penicillin and Streptomycin Market in Australia to 2019 - Market Size, Development, and Forecasts

  • $ 652
  • Industry report
  • August 2015
  • by Global Research & Data Services

The industry report Penicillin and Streptomycin Market in Australia to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook ...

  • Industries : Therapy
  • Countries : Australia

Insulin Market in Australia to 2019 - Market Size, Development, and Forecasts

  • $ 652
  • Industry report
  • August 2015
  • by Global Research & Data Services

The industry report Insulin Market in Australia to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for insulin in ...

  • Industries : Therapy
  • Countries : Australia

Vitamin and Provitamin Market in Australia to 2019 - Market Size, Development, and Forecasts

  • $ 652
  • Industry report
  • August 2015
  • by Global Research & Data Services

The industry report Vitamin and Provitamin Market in Australia to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook ...

  • Industries : OTC
  • Countries : Australia, Oceania

Herbert Smith Freehills - Pharmaceuticals & Healthcare - Advisory Profile

  • $ 250
  • Company report
  • July 2015
  • by GlobalData

Summary Herbert Smith Freehills (Herbert Smith) is a legal and advisory service provider that offers legal advises to various industries. The company’s practice areas include finance, tax, dispute resolution, ...

  • Industries : Healthcare
  • Countries : Australia

Aspen Pharmacare Australia Pty Ltd in Consumer Health (Australia)

  • $ 428
  • Company report
  • June 2015
  • by Euromonitor International

Aspen Pharmacare Australia is an innovation-driven company which seeks to operate, identify and pursue opportunities to bring to market drugs in specialist areas which are overlooked by the multinational ...

  • Industries : OTC
  • Countries : Australia

My Chemist Group in Consumer Health (Australia)

  • $ 428
  • Company report
  • June 2015
  • by Euromonitor International

My Chemist Group is currently the largest retail distributor of consumer health products in Australia, predominately through its Chemist Warehouse brand. Its positioning as a low-cost alternative to traditional ...

  • Industries : OTC
  • Countries : Australia

Blackmores New Zealand Ltd in Consumer Health (New Zealand)

  • $ 428
  • Company report
  • June 2015
  • by Euromonitor International

Blackmores (New Zealand) Ltd is expected to focus on widening its product offering, with a particular focus on sports nutrition and weight management. The company will also continue to concentrate on achieving ...

  • Industries : OTC
  • Countries : New Zealand

Calming and Sleeping in Australia

  • $ 912
  • Industry report
  • June 2015
  • by Euromonitor International

Similar to 2013, calming and sleeping in 2014 saw 6% current value growth, to reach AUD16 million. Growth was largely driven by the ageing population in Australia. As a person gets older, sleep becomes ...

  • Industries : OTC
  • Countries : Australia

Calming and Sleeping in New Zealand

  • $ 912
  • Industry report
  • June 2015
  • by Euromonitor International

During 2014 the purchasing decisions consumers made for calming and sleeping products shifted from brand-centric to price-focused, as they were becoming motivated by value for money in this category. This ...

  • Industries : OTC
  • Countries : New Zealand

Melanoma - Australia Drug Forecast and Market Analysis to 2023

  • $ 4995
  • Industry report
  • April 2015
  • by GlobalData

Melanoma - Australia Drug Forecast and Market Analysis to 2023 Summary Melanoma is the deadliest and most aggressive form of skin cancer. The major treatments for melanoma are categorized into immunotherapies ...

  • Industries : Therapy
  • Countries : World, Australia

PharmaPoint: Melanoma - Global Drug Forecast and Market Analysis to 2023

  • $ 10995
  • Industry report
  • April 2015
  • by GlobalData

PharmaPoint: Melanoma - Global Drug Forecast and Market Analysis to 2023 Summary Melanoma is the deadliest and most aggressive form of skin cancer. The major treatments for melanoma are categorized into ...

  • Industries : Therapy
  • Countries : World, Europe, United States, Japan, Australia

Melanoma - Current and Future Players

  • $ 2995
  • Industry report
  • April 2015
  • by GlobalData

Melanoma - Current and Future Players Summary GlobalData has released its pharma report, “Melanoma - Current and Future Players”. The report is a vital source of up-to-date information with in-depth ...

  • Industries : Therapy
  • Countries : United States, United Kingdom, World, Australia

Pharmaceutical, Laboratory and Hygienic Glassware Market in New Zealand to 2019 - Market Size, Trends, and Forecasts

  • $ 652
  • Industry report
  • February 2015
  • by Global Research & Data Services

This industry report offers the most up-to-date market data on the actual market situation, trends and future outlook for pharmaceutical, laboratory and hygienic glassware in New Zealand. The research ...

  • Industries : Houseware, Pharmaceutical, Home Goods
  • Countries : New Zealand, World

Pharmaceutical, Laboratory and Hygienic Glassware Market in Australia to 2019 - Market Size, Trends, and Forecasts

  • $ 652
  • Industry report
  • February 2015
  • by Global Research & Data Services

This industry report offers the most up-to-date market data on the actual market situation, trends and future outlook for pharmaceutical, laboratory and hygienic glassware in Australia. The research includes ...

  • Industries : Houseware, Pharmaceutical, Home Goods
  • Countries : Australia

Healthcare Industry in Australia – PEST Framework Analysis

  • $ 220
  • Industry report
  • January 2015
  • by Aruvian's R'search

Healthcare is the prevention, treatment, and management of illness and the preservation of mental and physical well being through the services offered by the medical, nursing, and allied health professions. ...

  • Industries : Healthcare
  • Countries : Australia

PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis to 2023

  • $ 4995
  • Industry report
  • December 2014
  • by GlobalData

PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the ...

  • Industries : Therapy, Pathology
  • Countries : Australia, Oceania

Sun Biomedical Limited (SBN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • December 2014
  • by GlobalData

Summary Sun Biomedical Limited (Sun Biomedical) is a publicly held Australia-based pharmaceutical company. The company through its subsidiaries engages in the research, development and manufacture of illicit ...

  • Industries : Pharmaceutical
  • Countries : Australia

Australia Advanced Wound Management Market Outlook to 2020

  • $ 2500
  • Industry report
  • October 2014
  • by GlobalData

Australia Advanced Wound Management Market Outlook to 2020 Summary GlobalData’s new report, "Australia Advanced Wound Management Market Outlook to 2020", provides key market data on the Australia Advanced ...

  • Industries : Medical Supply
  • Countries : Australia, Oceania

Brain Resource Limited (BRC) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • October 2014
  • by GlobalData

Summary Brain Resource Limited (BRL) is a healthcare service provider. The company carries out research and development of brain products. Its products include MyBrainSolutions, MyCalmBeat, WebNeuro and ...

  • Industries : Therapy, Mental Health
  • Countries : Australia, United States

PharmaPoint: Asthma - Australia Drug Forecast and Market Analysis to 2023

  • $ 4995
  • Industry report
  • August 2014
  • by GlobalData

PharmaPoint: Asthma - Australia Drug Forecast and Market Analysis to 2023 Summary Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented ...

  • Industries : Therapy
  • Countries : Australia

Pharmacybrands Ltd in Consumer Health (New Zealand)

  • $ 131
  • Company report
  • July 2014
  • by Euromonitor International

Pharmacybrands Ltd is expected to continue expanding its retail network of chemists/pharmacies across New Zealand through its five banners; Amcal, Care Chemist, Radius Pharmacy, Life Pharmacy and Unichem. ...

  • Industries : OTC
  • Countries : New Zealand

Global Skincare Market: Merger and Acquisitions May 2014

  • $ 295
  • Industry report
  • June 2014
  • by GlobalData

Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global skincare market during May 2014. Summary Using ...

  • Industries : Body Care
  • Countries : United States, New Zealand, World

Sigma Pharmaceuticals Ltd in Retailing (Australia)

  • $ 131
  • Company report
  • June 2014
  • by Euromonitor International

After a successful redefinition of its business strategy, Sigma Pharmaceuticals has been focusing on strengthening its pharmacy-based retail business. In the first quarter of 2013, Sigma Pharmaceuticals ...

  • Industries : Pharmaceutical
  • Countries : Australia

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3495
  • Industry report
  • May 2014
  • by GlobalData

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Mental Health, Pathology, Therapy
  • Countries : World, Australia

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3495
  • Industry report
  • May 2014
  • by GlobalData

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Therapy, Mental Health, Pathology
  • Countries : World, Australia

Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3495
  • Industry report
  • May 2014
  • by GlobalData

Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Mental Health, Therapy, Pathology
  • Countries : Australia, World

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3495
  • Industry report
  • May 2014
  • by GlobalData

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Mental Health, Therapy, Pathology
  • Countries : World, Australia, Japan

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.